Azithromycin mass drug administration to reduce child mortality in Niger (AVENIR II): a master protocol for a cluster-randomized adaptive platform trial to evaluate community-based health interventions
Authors
Carolyn Brandt
Ahmed M. Arzika (ORCID: https://orcid.org/0000-0001-7022-282X)
Azithromycin mass drug administration to reduce child mortality in Niger (AVENIR II): a master protocol for a cluster-randomized adaptive platform trial to evaluate community-based health interventions
Carolyn Brandt, Ahmed M. Arzika, Angela Cheng, Ibrahim Almou et al.
Journal
Trials
Topics
Global Maternal and Child Health
article
Azithromycin mass drug administration to reduce child mortality in Niger (AVENIR II): a master protocol for a cluster-randomized adaptive platform trial to evaluate community-based health interventions
Carolyn Brandt, Ahmed M. Arzika, Angela Cheng, Ibrahim Almou, Bawa Aichatou, Nasser Galo, Nasser Harouna, Kieran Sunanda O’Brien, Brittany F. Peterson, Thuy Doan, Ousseini Boubacar, Andrea Picariello, Abdou Amza, Ramatou Maliki, Benjamin F. Arnold, Alio Mankara, Travis C. Porco, Sani Ousmane, Thomas M. Lietman
article en
Abstract
No abstract available for this paper.
Publication Tag
TrialsVol. 27(1)
Institutions
University of California, San Francisco (US), San Francisco Foundation (US), Ministère de la Santé Publique (NE), Global Brain Health Institute (US)